FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

douglas veale

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Wei Gao; Jennifer McCormick; Peadar Rooney; Catherine Sweeney; douglas veale; Ceara Walsh; Ursula Fearon
Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.
Mary Connolly; Barry Bresnihan; Oliver FitzGerald; Aisling Kennedy; Clare Matthews; Jennifer McCormick; Ronan H Mullan; A Robin Poole; Owen Sullivan; douglas veale; Ursula Fearon
Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
L C Harty; C A Murray; Chin Teck Ng; C Fearon; Oliver FitzGerald; douglas veale
Joint tenderness and swelling in biologic-treated inflammatory arthritis patients - a tricky trade off?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of douglas veale (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wei Gao; Jennifer McCormick; Peadar Rooney; Catherine Sweeney; douglas veale; Ceara Walsh; Ursula Fearon
Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.
Annals of the rheumatic diseases 2013;72(6):1080-8.
2012: Mary Connolly; Barry Bresnihan; Oliver FitzGerald; Aisling Kennedy; Clare Matthews; Jennifer McCormick; Ronan H Mullan; A Robin Poole; Owen Sullivan; douglas veale; Ursula Fearon
Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
Arthritis and rheumatism 2012;64(4):1035-45.
2012: L C Harty; C A Murray; Chin Teck Ng; C Fearon; Oliver FitzGerald; douglas veale
Joint tenderness and swelling in biologic-treated inflammatory arthritis patients - a tricky trade off?
International journal of clinical practice 2012;66(2):128-31.
2011: Ellen Moran; Mary Connolly; Ursula Fearon; Wei Gao; Jennifer McCormick; douglas veale
Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangement.
Arthritis and rheumatism 2011;63(11):3263-73.
2011: M Connolly; douglas veale; U Fearon
Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis.
Annals of the rheumatic diseases 2011;70(7):1296-303.
2011: Monika Biniecka; Ting C Chang; Ursula Fearon; Edward Fox; Aisling Kennedy; Chin Teck Ng; Emese Balogh; douglas veale; Jacintha N O'Sullivan
Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis.
Arthritis research & therapy 2011;13(4):R121.
2011: Sinéad Nic An Ultaigh; Mary Connolly; Jérôme Dellacasagrande; Ursula Fearon; Brian Keogh; William McCormack; Jennifer McCormick; Peter McGuirk; Luke A O'Neill; Mary Reilly; Tajvur P Saber; douglas veale
Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures.
Arthritis research & therapy 2011;13(1):R33.
2011: Eliza K Pontifex; Paul Peter Tak; douglas veale; Marjolein Vinkenoog; Barry Bresnihan; Ilse Burgman; Ursula Fearon; Danielle M Gerlag; Adrian Gibbs; Robin G Gibney; Martina Gogarty; Oliver FitzGerald
Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.
Arthritis research & therapy 2011;13(1):R7.
2010: Terence Rooney; Carl K Edwards; Martina Gogarty; Laura Greenan; douglas veale; Oliver FitzGerald; Jean-Michel Dayer; Barry Bresnihan
Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.
Rheumatology international 2010;30(12):1571-80.
2010: Naila Usmani; A Murphy; douglas veale; Victoria Goulden; M J D Goodfield
Photochemotherapy for systemic sclerosis: effect on clinical and molecular markers.
Clinical and experimental dermatology 2010;35(6):608-13.
2010: Leonard Harty; douglas veale
How early should psoriatic arthritis be treated with a TNF-blocker?
Current opinion in rheumatology 2010;22(4):393-6.
2010: Anne-Marie Tobin; douglas veale; Oliver FitzGerald; Sarah Rogers; Paul Collins; Donal O'Shea; Brian Kirby
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
The Journal of rheumatology 2010;37(7):1386-94.
2010: Chin Teck Ng; M Biniecka; A Kennedy; J McCormick; Oliver FitzGerald; Barry Bresnihan; D Buggy; Cormac T Taylor; J O'Sullivan; Ursula Fearon; douglas veale
Synovial tissue hypoxia and inflammation in vivo.
Annals of the rheumatic diseases 2010;69(7):1389-95.
2010: M Englbrecht; Y Wang; M Ronneberger; Bernhard Manger; N Vastesaeger; douglas veale; Georg Schett
Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives.
Arthritis care & research 2010;62(7):977-83.
2010: Mary Connolly; Alessandra Marrelli; Mark Blades; Jennifer McCormick; Paola Maderna; Catherine Godson; Ronan Mullan; Oliver FitzGerald; Barry Bresnihan; Costantino Pitzalis; douglas veale; Ursula Fearon
Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(11):6427-37.
2010: Monika Biniecka; Aisling Kennedy; Ursula Fearon; Chin Teck Ng; douglas veale; Jacintha N O'Sullivan
Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint.
Annals of the rheumatic diseases 2010;69(6):1172-8.
2010: Patricia Minnock; John Kirwan; douglas veale; Oliver FitzGerald; Barry Bresnihan
Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritis.
Clinical and experimental rheumatology 2010;28(3):401-4.
2010: Leonard C Harty; douglas veale
Irish smokers with rheumatoid arthritis suffer more than their nonsmoking counterparts.
The Journal of rheumatology 2010;37(5):1062; author reply 1063.
2010: Ronan Hugh Mullan; Jennifer McCormick; Mary Connolly; Barry Bresnihan; douglas veale; Ursula Fearon
A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.
The American journal of pathology 2010;176(4):1999-2008.
2010: Terence Rooney; Pascale Roux-Lombard; douglas veale; Oliver FitzGerald; Jean-Michel Dayer; Barry Bresnihan
Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade.
Annals of the rheumatic diseases 2010;69(4):706-14.
2010: douglas veale
What can we learn from negative clinical trials in systemic sclerosis?
Clinical and experimental rheumatology 2010;28(2 Suppl 58):S1-4.
2010: Aisling Kennedy; Chin Teck Ng; Monika Biniecka; Tajvur Saber; Cormac Taylor; Jacintha O'Sullivan; douglas veale; Ursula Fearon
Angiogenesis and blood vessel stability in inflammatory arthritis.
Arthritis and rheumatism 2010;62(3):711-21.
2010: Chin Teck Ng; C T Ng; Guillaume Renard; Bernadette M Lynch; Eliza Pontifex; Ceara A E Walsh; Alexia Grier; Marian Molloy; Barry Bresnihan; Oliver FitzGerald; Ursula Fearon; douglas veale
Remission in psoriatic arthritis: is it possible and how can it be predicted?
Arthritis research & therapy 2010;12(3):R94.
2010: Roisin Adams; Cathal Walsh; douglas veale; Barry Bresnihan; Oliver FitzGerald; Michael Barry
Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
PharmacoEconomics 2010;28(6):477-87.
2010: Chin Teck Ng; B J Radovits; W Kievit; Jaap Fransen; P L C M van Riel; O FitzGerald; douglas veale; B Bresnihan
Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing.
Annals of the rheumatic diseases 2010;69(1):313-4.
2010: J Martin; C Walsh; A Gibbs; T McDonnell; Ursula Fearon; J Keane; M B Codd; J Dodd; douglas veale; Oliver FitzGerald; Barry Bresnihan
Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
Annals of the rheumatic diseases 2010;69(1):181-5.
2009: Kathryn M Oliver; John F Garvey; Chin Teck Ng; douglas veale; Ursula Fearon; Eoin P Cummins; Cormac T Taylor
Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway.
Antioxidants & redox signaling 2009;11(9):2057-64.
2009: Barry Bresnihan; Eliza Pontifex; Rogier M Thurlings; Marjolein Vinkenoog; Hani El-Gabalawy; Ursula Fearon; Oliver FitzGerald; Danielle M Gerlag; Terence Rooney; Marleen G van de Sande; douglas veale; Koen Vos; Paul P Tak
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
The Journal of rheumatology 2009;36(8):1800-2.
2009: Tajvur P Saber; douglas veale
Psoriatic arthritis management update - biotherapeutic options.
The Journal of rheumatology. Supplement 2009;83():65-8.
2009: L Pearman; J Last; O Fitzgerald; douglas veale; M Joyce; L Rainford; M McEntee; J McNulty; E Thomas; J Ryan; A McGee; R Toomey; C D'Helft; J Lowe; Patrick C Brennan
Rheumatoid arthritis: a novel radiographic projection for hand assessment.
The British journal of radiology 2009;82(979):554-60.
2009: Lynda Doward; Stephen P McKenna; Diane Whalley; Alan Tennant; B Griffiths; P Emery; douglas veale
The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus.
Annals of the rheumatic diseases 2009;68(2):196-200.
2009: Ellen Moran; Ronan Mullan; Jennifer McCormick; Mary Connolly; Owen Sullivan; Oliver Fitzgerald; Barry Bresnihan; douglas veale; Ursula Fearon
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.
Arthritis research & therapy 2009;11(4):R113.
2008: Naila Usmani; A Murphy; douglas veale; Victoria Goulden; M J D Goodfield
Photochemotherapy for localized morphoea: effect on clinical and molecular markers.
Clinical and experimental dermatology 2008;33(6):698-704.
2008: J P Doran; douglas veale
Biomarkers in systemic sclerosis.
Rheumatology (Oxford, England) 2008;47 Suppl 5():v36-8.
2008: douglas veale; A D Woolf; A J Carr
Chronic musculoskeletal pain and arthritis: impact, attitudes and perceptions.
Irish medical journal 2008;101(7):208-10.
2008: C A E Walsh; Ursula Fearon; Oliver FitzGerald; douglas veale; Barry Bresnihan
Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy.
Clinical and experimental rheumatology 2008;26(4):656-8.
2008: Peter A Merkel; Nancy P Silliman; Christopher P Denton; Daniel E Furst; Dinesh Khanna; Paul Emery; Vivien M Hsu; James B Streisand; Richard P Polisson; Anita Akesson; John Coppock; Frank van den Hoogen; Ariane Herrick; MD Mayes; douglas veale; James R Seibold; Carol M Black; Joseph H Korn
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Arthritis and rheumatism 2008;59(5):699-705.
2008: Marina O'Kane; Trevor Markham; Alice N McEvoy; Ursula Fearon; douglas veale; Oliver FitzGerald; Brian Kirby; Evelyn P Murphy
Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition.
The Journal of investigative dermatology 2008;128(2):300-10.
2007: Darren Greetham; Charles D Ellis; Devesh Mewar; Ursula Fearon; Sinead Nic an Ultaigh; douglas veale; François Guesdon; Anthony G Wilson
Functional characterization of NF-kappaB inhibitor-like protein 1 (NFkappaBIL1), a candidate susceptibility gene for rheumatoid arthritis.
Human molecular genetics 2007;16(24):3027-36.
2007: Terence Rooney; Barry Bresnihan; Ulf Andersson; Martina Gogarty; Maarten C Kraan; H Ralph Schumacher; Ann-Kristin Ulfgren; douglas veale; Peter P Youssef; Paul P Tak
Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis.
Annals of the rheumatic diseases 2007;66(12):1656-60.
2007: Ronan H Mullan; Clare Matthews; Barry Bresnihan; Oliver FitzGerald; Lindsay King; A Robin Poole; Ursula Fearon; douglas veale
Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy.
Arthritis and rheumatism 2007;56(9):2919-28.
2007: Dafna D Gladman; Robert D Inman; Richard J Cook; Walter P Maksymowych; Jurgen Braun; John C Davis; Robert B M Landewé; Philip J Mease; Joachim Brandt; Ruben Burgos Vargas; Vinod Chandran; Philip Helliwell; Arthur Kavanaugh; Finbar D O'Shea; Muhammad A Khan; Nicolò Pipitone; Proton Rahman; John D Reveille; Millicent A Stone; William Taylor; douglas veale; Désirée van der Heijde
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis.
The Journal of rheumatology 2007;34(8):1740-5.
2007: Dafna D Gladman; Robert D Inman; Richard J Cook; Désirée van der Heijde; Robert B M Landewé; Jurgen Braun; John C Davis; Philip J Mease; Joachim Brandt; Ruben Burgos Vargas; Vinod Chandran; Philip Helliwell; Arthur Kavanaugh; Finbar D O'Shea; Muhammad A Khan; Nicolò Pipitone; Proton Rahman; John D Reveille; Millicent A Stone; William Taylor; douglas veale; Walter P Maksymowych
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures.
The Journal of rheumatology 2007;34(8):1733-9.
2007: C A E Walsh; Patricia Minnock; C Slattery; Norelee Kennedy; F Pang; douglas veale; Barry Bresnihan; Oliver FitzGerald
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2007;46(7):1148-52.
2007: Helena Marzo-Ortega; Dennis McGonagle; Laura A Rhodes; Ai Lyn Tan; Philip Conaghan; Philip O'Connor; Steven F Tanner; Alexander Fraser; douglas veale; Paul Emery
Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis.
Annals of the rheumatic diseases 2007;66(6):778-81.
2007: Dafna D Gladman; Philip J Mease; Paul Healy; Philip S Helliwell; Oliver Fitzgerald; Alberto Cauli; Ennio Lubrano; Gerald G Krueger; Désirée van der Heijde; douglas veale; Arthur Kavanaugh; Peter Nash; Christopher T Ritchlin; William Taylor; Vibeke Strand
Outcome measures in psoriatic arthritis.
The Journal of rheumatology 2007;34(5):1159-66.
2007: Barry Bresnihan; Danielle M Gerlag; Terence Rooney; Tom J M Smeets; Carla A Wijbrandts; David Boyle; Oliver FitzGerald; Bruce W Kirkham; Iain B McInnes; Malcolm Smith; Ann-Kristin Ulfgren; douglas veale; Paul P Tak
Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.
The Journal of rheumatology 2007;34(3):620-2.
2007: Ursula Fearon; douglas veale
Angiogenesis in arthritis: methodological and analytical details.
Methods in molecular medicine 2007;135():343-57.
2007: Christopher P Denton; Peter A Merkel; Daniel E Furst; Dinesh Khanna; Paul Emery; Vivien M Hsu; Nancy Silliman; James Streisand; John Powell; Anita Akesson; John Coppock; Frank van den Hoogen; Ariane Herrick; MD Mayes; douglas veale; Joanna Haas; Stephen Ledbetter; Joseph H Korn; Carol M Black; James R Seibold
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.
Arthritis and rheumatism 2007;56(1):323-33.
2006: Rachel K Hoyles; Ross W Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlands; Nicole S L Goh; Christopher Roberts; Sujal Desai; Ariane L Herrick; Neil J McHugh; Noeleen M Foley; Stanley B Pearson; Paul Emery; douglas veale; Christopher P Denton; Athol U Wells; Carol M Black; Roland M Du Bois
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Arthritis and rheumatism 2006;54(12):3962-70.
2006: Trevor Markham; C Mathews; S Rogers; Ronan H Mullan; B Bresnihan; O Fitzgerald; douglas veale; Ursula Fearon
Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
The British journal of dermatology 2006;155(6):1191-6.
2006: Ursula Fearon; Ronan H Mullan; Trevor Markham; Mary Connolly; Shane Sullivan; A Robin Poole; Oliver FitzGerald; Barry Bresnihan; douglas veale
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Arthritis and rheumatism 2006;54(10):3152-62.
2006: douglas veale; Ursula Fearon
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
Best practice & research. Clinical rheumatology 2006;20(5):941-7.
2006: Trevor Markham; Ronan H Mullan; Lucy Golden-Mason; Sarah Rogers; Barry Bresnihan; Oliver FitzGerald; Ursula Fearon; douglas veale
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Journal of the American Academy of Dermatology 2006;54(6):1003-12.
2006: Deborah Symmons; Mark Lunt; Gillian Watkins; Philip Helliwell; Sharon Jones; Neil McHugh; douglas veale
Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard".
The Journal of rheumatology 2006;33(3):552-7.
2006: Ronan H Mullan; Barry Bresnihan; Lucy Golden-Mason; Trevor Markham; Rosemary O'Hara; Oliver FitzGerald; douglas veale; Ursula Fearon
Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway.
Arthritis and rheumatism 2006;54(1):105-14.
2006: Malcolm D Smith; D Baeten; A-K Ulfgren; I B McInnes; Oliver FitzGerald; B Bresnihan; Paul P Tak; douglas veale
Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?
Annals of the rheumatic diseases 2006;65(1):93-100.
2005: Barry Bresnihan; Dominique Baeten; Gary S Firestein; Oliver FitzGerald; Danielle M Gerlag; Jasper J Haringman; Iain B McInnes; Richard J Reece; Malcolm D Smith; Ann-Kristin Ulfgren; douglas veale; Paul P Tak
Synovial tissue analysis in clinical trials.
The Journal of rheumatology 2005;32(12):2481-4.
2005: M J Benito; douglas veale; Oliver FitzGerald; W B van den Berg; Barry Bresnihan
Synovial tissue inflammation in early and late osteoarthritis.
Annals of the rheumatic diseases 2005;64(9):1263-7.
2005: Tai Teck Leong; Ursula Fearon; douglas veale
Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.
Current rheumatology reports 2005;7(4):325-9.
2005: A D Fraser; A W R van Kuijk; R Westhovens; Zunaid Karim; Richard J Wakefield; A H Gerards; R Landewé; Serge D Steinfeld; Paul Emery; B A C Dijkmans; douglas veale
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
Annals of the rheumatic diseases 2005;64(6):859-64.
2005: douglas veale; Christopher T Ritchlin; Oliver FitzGerald
Immunopathology of psoriasis and psoriatic arthritis.
Annals of the rheumatic diseases 2005;64 Suppl 2():ii26-9.
2005: Frederique Ponchel; Robert J Verburg; Sarah J Bingham; Andrew K Brown; John Moore; Andrew Protheroe; Kath Short; Catherine A Lawson; Ann W Morgan; Mark Quinn; Maya H Buch; Sarah L Field; Sarah L Maltby; Aurelie Masurel; Susan H Douglas; Liz Straszynski; Ursula Fearon; douglas veale; Poulam Patel; Dennis McGonagle; John Snowden; Alexander F Markham; David Ma; Jacob M van Laar; Helen A Papadaki; Paul Emery; John D Isaacs
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.
Arthritis research & therapy 2005;7(1):R80-92.
2004: Maya H Buch; Philip Conaghan; Mark A Quinn; Sarah J Bingham; douglas veale; Paul Emery
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
Annals of the rheumatic diseases 2004;63(10):1344-6.
2004: A D Woolf; H Zeidler; U Haglund; A J Carr; S Chaussade; D Cucinotta; douglas veale; E Martin-Mola
Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries.
Annals of the rheumatic diseases 2004;63(4):342-7.
2004: Zunaid Karim; Richard J Wakefield; Mark Quinn; Philip Conaghan; Andrew K Brown; douglas veale; Philip O'Connor; R Reece; Paul Emery
Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination.
Arthritis and rheumatism 2004;50(2):387-94.
2004: Stephen P McKenna; Lynda Doward; Diane Whalley; Alan Tennant; P Emery; douglas veale
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis.
Annals of the rheumatic diseases 2004;63(2):162-9.
2003: Alexander Fraser; Ursula Fearon; R Clark Billinghurst; Mirela Ionescu; Richard Reece; Thomas Barwick; Paul Emery; A Robin Poole; douglas veale
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Arthritis and rheumatism 2003;48(11):3085-95.
2003: M Ali; douglas veale; Richard Reece; Mark Quinn; Karen Henshaw; Edward Zanders; Alexander F Markham; Paul Emery; John D Isaacs
Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(7):663-6.
2003: Catherine A Lawson; A Fraser; douglas veale; Paul Emery
Cyclosporin treatment in psoriatic arthritis: a cause of severe leg pain.
Annals of the rheumatic diseases 2003;62(5):489.
2003: Ursula Fearon; Konstantina Griosios; Alexander Fraser; Richard Reece; Paul Emery; Pam Jones; douglas veale
Angiopoietins, growth factors, and vascular morphology in early arthritis.
The Journal of rheumatology 2003;30(2):260-8.
2003: Gabriele Valentini; A J Silman; douglas veale
Assessment of disease activity.
Clinical and experimental rheumatology 2003;21(3 Suppl 29):S39-41.
2002: douglas veale; Oliver FitzGerald
Psoriatic arthritis--pathogenesis and epidemiology.
Clinical and experimental rheumatology 2002;20(6 Suppl 28):S27-33.
2002: Bridget Griffiths; Sarah Miles; Hilary Moss; Rod Robertson; douglas veale; Paul Emery
Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
The Journal of rheumatology 2002;29(11):2371-8.
2002: douglas veale; Oliver FitzGerald
Psoriatic arthritis.
Best practice & research. Clinical rheumatology 2002;16(4):523-35.
2002: Maarten C Kraan; Richard J Reece; Tom J M Smeets; douglas veale; Paul Emery; Paul P Tak
Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.
Arthritis and rheumatism 2002;46(8):2034-8.
2002: Sarah Bingham; douglas veale; Ursula Fearon; John D Isaacs; Gareth Morgan; Paul Emery; Dennis McGonagle; Richard Reece; Roy Clague; John A Snowden
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.
Arthritis and rheumatism 2002;46(3):837-9.
2002: David Kane; douglas veale; Oliver FitzGerald; R Reece
Survey of arthroscopy performed by rheumatologists.
Rheumatology (Oxford, England) 2002;41(2):210-5.
2002: Richard Reece; Maarten C Kraan; Aleksandra Radjenovic; douglas veale; Philip J O'Connor; John P Ridgway; Wayne W Gibbon; Ferdinand C Breedveld; Paul P Tak; Paul Emery
Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.
Arthritis and rheumatism 2002;46(2):366-72.
2002: Ruth Z Lee; douglas veale
Management of spondyloarthropathy: new pharmacological treatment options.
Drugs 2002;62(16):2349-59.
2001: Ursula Fearon; douglas veale
Pathways of cell activation in spondyloarthropathies.
Current rheumatology reports 2001;3(5):435-42.
2001: Alexander Fraser; Ursula Fearon; Richard Reece; Paul Emery; douglas veale
Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Arthritis and rheumatism 2001;44(9):2024-8.
2001: Ursula Fearon; douglas veale
Pathogenesis of psoriatic arthritis.
Clinical and experimental dermatology 2001;26(4):333-7.
2001: S Patel; douglas veale; O FitzGerald; N J McHugh
Psoriatic arthritis--emerging concepts.
Rheumatology (Oxford, England) 2001;40(3):243-6.
2001: Karen E Kempsell; Charles J Cox; A A McColm; J A Bagshaw; R Reece; douglas veale; P Emery; J D Isaacs; J S Hill Gaston; J S Crowe
Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis.
Infection and immunity 2001;69(3):1821-31.
2001: P Harrington; P A Millner; douglas veale
Inappropriate medical management of spinal epidural abscess.
Annals of the rheumatic diseases 2001;60(3):218-22.
2001: Manir Ali; Frederique Ponchel; K E Wilson; M J Francis; X Wu; Adrienne Verhoef; Arthur W Boylston; douglas veale; Paul Emery; Alexander F Markham; Jonathan R Lamb; John D Isaacs
Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy.
The Journal of clinical investigation 2001;107(4):519-28.
2000: Helena Marzo-Ortega; D McGonagle; douglas veale; P Emery
Case definition of psoriatic arthritis.
Lancet 2000;356(9247):2095; author reply 2096.
2000: Richard J Wakefield; Wayne W Gibbon; Philip Conaghan; Philip O'Connor; Dennis McGonagle; Colin Pease; Michael J Green; douglas veale; John D Isaacs; Paul Emery
The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.
Arthritis and rheumatism 2000;43(12):2762-70.
2000: A Fraser; douglas veale
What practical skills do rheumatologists of the future need?
Baillière's best practice & research. Clinical rheumatology 2000;14(4):635-48.
2000: Maarten C Kraan; R J Reece; EC Barg; Tom J M Smeets; J Farnell; R Rosenburg; douglas veale; Ferdinand C Breedveld; P Emery; Paul P Tak
Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
Arthritis and rheumatism 2000;43(8):1820-30.
2000: Susanna M Proudman; Philip Conaghan; C Richardson; Bridget Griffiths; Michael J Green; Dennis McGonagle; Richard J Wakefield; Richard Reece; S Miles; Ade Adebajo; A K S Gough; Philip Helliwell; M Martin; G Huston; Colin Pease; douglas veale; John Isaacs; Désirée van der Heijde; Paul Emery
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.
Arthritis and rheumatism 2000;43(8):1809-19.
2000: R J Wakefield; P Emery; douglas veale
Ultrasonography and psoriatic arthritis.
The Journal of rheumatology 2000;27(6):1564-5.
2000: douglas veale
The epidemiology of psoriatic arthritis: fact or fiction?
The Journal of rheumatology 2000;27(5):1105-6.
2000: Philip S Helliwell; J Hetthen; Katharina Sokoll; M Green; Antonio Marchesoni; Ennio Lubrano; douglas veale; Paul Emery
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model.
Arthritis and rheumatism 2000;43(4):865-71.
2000: M Ho; douglas veale; C Eastmond; G Nuki; J Belch
Macrovascular disease and systemic sclerosis.
Annals of the rheumatic diseases 2000;59(1):39-43.
1999: Philip Conaghan; S Sommer; Dennis McGonagle; douglas veale; H Waldmann; G Hale; M Goodfield; Paul Emery; John Isaacs
The relationship between pityriasis rubra pilaris and inflammatory arthritis: case report and response of the arthritis to anti-tumor necrosis factor immunotherapy.
Arthritis and rheumatism 1999;42(9):1998-2001.
1999: Richard Reece; J D Canete; Wendy J Parsons; Paul Emery; douglas veale
Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis.
Arthritis and rheumatism 1999;42(7):1481-4.
1999: Ursula Fearon; Richard Reece; Jacqueline Smith; P Emery; douglas veale
Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients.
Annals of the New York Academy of Sciences 1999;878():619-21.
1999: douglas veale; Richard Reece; Wendy J Parsons; Aleksandra Radjenovic; Philip J O'Connor; C S Orgles; Elizabeth Berry; John P Ridgway; U Mason; Arthur W Boylston; Wayne W Gibbon; Paul Emery
Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology.
Annals of the rheumatic diseases 1999;58(6):342-9.
1999: D McGonagle; Wayne W Gibbon; Philip O'Connor; D Blythe; Richard J Wakefield; M Green; douglas veale; Paul Emery
A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(4):329-31.
1999: douglas veale
The role of arthroscopy in early arthritis.
Clinical and experimental rheumatology 1999;17(1):37-8.
1998: douglas veale; G Kirk; Margaret McLaren; Jill J F Belch
Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis.
British journal of rheumatology 1998;37(11):1227-8.
1998: Ennio Lubrano; Philip Helliwell; Wendy J Parsons; Paul Emery; douglas veale
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire.
The Journal of rheumatology 1998;25(8):1560-5.
1998: C Maple; G Kirk; Margaret McLaren; douglas veale; Jill J F Belch
A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers.
Clinical science (London, England : 1979) 1998;94(5):537-40.
1998: Ennio Lubrano; Philip Helliwell; P Moreno; Bridget Griffiths; Paul Emery; douglas veale
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire.
British journal of rheumatology 1998;37(4):437-41.
1998: Peter P Youssef; Maarten C Kraan; F Breedveld; Barry Bresnihan; N Cassidy; Gaye Cunnane; Paul Emery; Oliver FitzGerald; David Kane; Staffan Lindblad; Richard Reece; douglas veale; Paul P Tak
Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy.
Arthritis and rheumatism 1998;41(4):663-9.
1998: douglas veale; C Maple; G Kirk; Margaret McLaren; Jill J F Belch
Soluble cell adhesion molecules--P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis.
Scandinavian journal of rheumatology 1998;27(4):296-9.
1997: Faisel Khan; SJ Litchfield; Margaret McLaren; douglas veale; RC Littleford; Jill J F Belch
Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.
Arthritis and rheumatism 1997;40(2):352-7.
1996: douglas veale; C Maple
Cell adhesion molecules in rheumatoid arthritis.
Drugs & aging 1996;9(2):87-92.
1996: D M Mulherin; douglas veale; J J Belch; Barry Bresnihan; Oliver FitzGerald
Adhesion molecules in untreated inflammatory arthritis: synovial expression and levels in synovial fluid and serum [corrected].
QJM : monthly journal of the Association of Physicians 1996;89(3):195-203.
1995: douglas veale; T A Collidge; Jill J F Belch
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.
Annals of the rheumatic diseases 1995;54(10):853-5.
1995: douglas veale; M Ho; K D Morley
Sulphasalazine-induced lupus in psoriatic arthritis.
British journal of rheumatology 1995;34(4):383-4.
1995: C D'Arrigo; J J Candal-Couto; M Greer; douglas veale; Jenny M Woof
Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest.
Clinical and experimental immunology 1995;100(1):173-9.
1995: douglas veale; A H Muir; K D Morley; J J Belch
Treatment of vasculitic leg ulcers in connective tissue disease with iloprost.
Clinical rheumatology 1995;14(2):187-90.
1995: douglas veale; S Rogers; O Fitzgerald
Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin.
The British journal of dermatology 1995;132(1):32-8.
1994: douglas veale; H I Torley; I M Richards; A O'Dowd; C Fitzsimons; Jill J F Belch; R D Sturrock
A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis.
British journal of rheumatology 1994;33(10):954-8.
1994: A F Maggs; douglas veale
Lyme disease in Scotland.
Scottish medical journal 1994;39(4):99-100.
1994: douglas veale; L Barnes; S Rogers; Oliver FitzGerald
Immunohistochemical markers for arthritis in psoriasis.
Annals of the rheumatic diseases 1994;53(7):450-4.
1994: douglas veale; S Rogers; Oliver FitzGerald
Classification of clinical subsets in psoriatic arthritis.
British journal of rheumatology 1994;33(2):133-8.
1993: J J Belch; douglas veale; T Colleridge
Large vessel disease in CREST.
Annals of the rheumatic diseases 1993;52(11):837-8.
1993: douglas veale
Future developments in arthritis therapy.
Irish medical journal 1993;86(6):176-7.
1993: douglas veale; Jill J F Belch
A physician's approach to vasospasm.
Scottish medical journal 1993;38(5):133-5.
1993: douglas veale; Oliver FitzGerald
Sympathetic nervous system in chronic joint pain.
Annals of the rheumatic diseases 1993;52(7):552.
1993: douglas veale; G Yanni; S Rogers; L Barnes; Barry Bresnihan; Oliver FitzGerald
Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.
Arthritis and rheumatism 1993;36(7):893-900.
1993: T Cunningham; J Farrell; douglas veale; Oliver FitzGerald
Anterior mediastinal fibrosis with superior vena caval obstruction complicating the synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome.
British journal of rheumatology 1993;32(5):408-10.
1993: T Pullar; douglas veale
Cytotoxic therapy in rheumatoid arthritis.
British journal of rheumatology 1993;32(5):355-6.
1993: douglas veale; M Farrell; O Fitzgerald
Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia.
British journal of rheumatology 1993;32(5):413-6.
1992: douglas veale; O FitzGerald
Psoriatic arthritis--"DIP or not DIP? That is the question".
British journal of rheumatology 1992;31(6):430-1.
1992: douglas veale; G Yanni; Barry Bresnihan; Oliver FitzGerald
Production of angiotensin converting enzyme by rheumatoid synovial membrane.
Annals of the rheumatic diseases 1992;51(4):476-80.
1991: douglas veale; G Kavanagh; JF Fielding; Oliver FitzGerald
Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process.
British journal of rheumatology 1991;30(3):220-2.